LIXAZINONE
UNII 0FK7P66P1X

Substance Identification & Data

This profile provides standardized clinical and technical data for Lixazinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0FK7P66P1X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 94192-59-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
0FK7P66P1X
CAS Registry Number
94192-59-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LIXAZINONE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C21H28N4O3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
WUECXCBONAGRSA-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
INN ID
6141
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C1CCCC(N(C(CCCOc2cc3c(cc2)NC=4N(C3)CC(N4)=O)=O)C)C1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lixazinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LIXAZINONE

Common Names & Synonyms

LIXAZINONE [INN]

Systematic Nomenclature

BUTANAMIDE, N-CYCLOHEXYL-N-METHYL-4-((1,2,3,5-TETRAHYDRO-2-OXOIMIDAZO(2,1-B)QUINAZOLIN-7-YL)OXY)-